Inspire Medical price target raised to $252 from $240 at Baird
The Fly

Inspire Medical price target raised to $252 from $240 at Baird

Baird analyst David Rescott raised the firm’s price target on Inspire Medical (INSP) to $252 from $240 and keeps an Outperform rating on the shares. The firm said they remain a best-in-class idea after the company delivered another revenue/EPS beat/raise with +33% revenue growth, 7% OM, and confirmed FY25 CNS revenue growth estimates.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App